Tripple Infection of HBsAg and HCV Co-Infection Among HIV Seropositive Patients

Abstract

Human Immuno deficiency virus(HIV) pandemic is an undisputable reality of our time with socio political implication and unrelenting morbidity and mortality profiles.250 laboratory and clinical confirmed HIV infected patients which comprises of 119 male and 131 females, out of the sample analyzed for HBsAg,HCV,and HBsAg and HCV co infection.13.2%(n=33) were positive for HBsAg and 86.8% (n=217) negative, while 7.6%(n=19)were positive for HCV and 92.4%(n=231) negative for HCV and 4.0%(n=10) were positive for HBsAg and HCV co infection and 96.6%(n=240) negative for HBsAg and HCV co infection. The age and sex distribution of HBsAg HCV co infection  shows a prevalence rate of 3.4%(n=4)were positive and 96.4%(n=115)were negative among the male, while the females shows 4.6%(n=6) were positive and 95.4%(n=125) were negative .the age between 20-25 have the highest prevalence of 63.3%  among the female compare to that of male 36.7%.yhe  CD4+ T-lymphocytes count of BBV and HCV co infection was significant(177.2±134.7) at p=0.2.this is an indications that HBV and HCV decreases  CD4+ T –lymphocytes count and could in turn affects the immune system and the management of the patients. It is therefore suggested that HBV and HCV should be included as a routine screening for HIV patients also provide a justification for implementation of the policy for effective management of HIV positive clients.